Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Disparities in Trends of Gastroenteropancreatic Neuroendocrine Tumor Incidence.
Journal: JAMA oncology
Published: May 22, 2025
Disparities in Trends of Gastroenteropancreatic Neuroendocrine Tumor Incidence-Reply.
Journal: JAMA oncology
Published: May 22, 2025
Gastroenteropancreatic Neuroendocrine Tumor Incidence by Sex and Age in the US.
Journal: JAMA oncology
Published: January 17, 2025
Systemic Cancer Hallmarks as Novel Markers Associated with Progression-Free Survival in Gastroenteropancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.
Journal: Neuroendocrinology
Published: August 16, 2024
Initial validation of the clinical significance of the NETest in Japanese gastroenteropancreatic neuroendocrine tumor patients.
Journal: Endocrine journal
Published: July 28, 2024
Identification of gastroenteropancreatic neuroendocrine tumor patients with high liver tumor burden based on clinicopathological features.
Journal: BMC cancer
Published: May 16, 2024
Quantitative SPECT/CT Metrics in Early Prediction of [177Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor Patients.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 16, 2024
Virtual Care for Patients with Advanced Well Differentiated Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
Journal: Current oncology (Toronto, Ont.)
Published: December 19, 2023
Choosing the best systemic treatment sequence for control of tumour growth in gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): What is the recent evidence?
Journal: Best practice & research. Clinical endocrinology & metabolism
Published: November 01, 2023
The prognostic role of whole-body volumetric 68 GA-DOTATATE PET/computed tomography parameters in patients with gastroenteropancreatic neuroendocrine tumor treated with 177 LU-DOTATATE.
Journal: Nuclear medicine communications
Published: April 11, 2023
Gastroenteropancreatic Neuroendocrine Tumor Diagnosis: DOTATATE PET/CT.
Journal: PET clinics
Published: December 30, 2022
Last Updated: 10/31/2025